In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS - PubMed (original) (raw)
- PMID: 6214446
In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS
J Takeshita et al. Gan. 1982 Apr.
Abstract
The organ specificity and pharmacokinetics of SMANCS, poly (maleic acid-styrene)-conjugated neocarzinostatin (NCS), were investigated in rats. The drug activity accumulated primarily in the regional lymph nodes after subcutaneous injection. After intravenous injection, the drug was found in the kidney, lymph nodes, and bladder in very high concentrations, and in lesser concentrations in the bone marrow, lung, small intestine, liver and spleen. The urinary excretion rate and total recovery of the drug after intravenous injection were higher than those after subcutaneous injection. SMANCS, having a molecular weight of 2.5 x 10(4) daltons, was degraded in vivo to NCS (mol. wt. about 1.1 x 10(4)). This was also confirmed in vitro by incubating the drug with cell homogenates. SMANCS caused strand scission of DNA similarly to NCS in lymphoblastoid cells. However, in a cell-free system using colicin E1 plasmid DNA, a high concentration of SMANCS was required to produce DNA degradation detectable by the alkaline sucrose gradient method.
Similar articles
- [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
Suzuki F, Okuno Y, Maeda Y, Maeda H. Suzuki F, et al. Gan To Kagaku Ryoho. 1987 Dec;14(12):3305-12. Gan To Kagaku Ryoho. 1987. PMID: 2961306 Japanese. - Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
Oda T, Sato F, Maeda H. Oda T, et al. J Natl Cancer Inst. 1987 Dec;79(6):1205-11. J Natl Cancer Inst. 1987. PMID: 2961908 - Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
Abe S, Otsuki M. Abe S, et al. Curr Med Chem Anticancer Agents. 2002 Nov;2(6):715-26. doi: 10.2174/1568011023353679. Curr Med Chem Anticancer Agents. 2002. PMID: 12678722 Review.
Cited by
- Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.
Tsukigawa K, Liao L, Nakamura H, Fang J, Greish K, Otagiri M, Maeda H. Tsukigawa K, et al. Cancer Sci. 2015 Mar;106(3):270-8. doi: 10.1111/cas.12592. Epub 2015 Feb 3. Cancer Sci. 2015. PMID: 25529761 Free PMC article. - The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect.
Maeda H. Maeda H. Cancer Sci. 2013 Jul;104(7):779-89. doi: 10.1111/cas.12152. Epub 2013 Apr 22. Cancer Sci. 2013. PMID: 23495730 Free PMC article. Review. - Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting.
Maeda H. Maeda H. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(3):53-71. doi: 10.2183/pjab.88.53. Proc Jpn Acad Ser B Phys Biol Sci. 2012. PMID: 22450535 Free PMC article. Review. - Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure.
Li CJ, Miyamoto Y, Kojima Y, Maeda H. Li CJ, et al. Br J Cancer. 1993 May;67(5):975-80. doi: 10.1038/bjc.1993.179. Br J Cancer. 1993. PMID: 8494731 Free PMC article.